
--- Page 1 ---
UUID: BDE9E2A9-09E9-49BC-AFBE-BD32916972DC TCGA-C8-A275-01A-PR Redacted IrB ApprOVeD Multi-media systems inc. Form Revised  Clinica! Case Report 1co-0-3 (For Collection of Cancerous Tissue) carcn om, ifiItnathy Criteri duct, Nos 85oof3 agrois Ds Discrepan Site; breast, Nos cSo.9 hw 3f2ufn Informed Consent 3/20 I personally informed this patient that a specimen(s) would be collected to be used for research. purposes. I reviewed the RESEARCH SUBJECT INFORMATION AND CONSENT FORM with the patient and answered any questions the patient had. The patient then signed the. consent form as a free and voluntary act. A copy of this informed consent document will be retained at our institution. Name of Physician or Study Coordinator. Signature Date Clinical Information RATA GENERALINFORMATIONO Date of Birth (mm/dd/yyyy) Height Marital Status Race Temperature  Single Married S6.sc Gender Weight  Divorced  Widow  Blood Pressure Heart Rate  Male . tFemale 137n m83m  MRAM TTHISTORY OEPRESENT ILLNESS: Chief Complaints: thret baat+ Symptoms: Clinical Findings: rmFy He lTbseat has 3r3 pu-kvd, nnnble tum. ymphnpleere Performance Scale (Karnofsky Score): eul  100 Asymptomatic   80-90 Symptomatic but Fully Ambulatory   60-70 Symptomatic, in bed less than 50% of day.  40-50 Symptomatic, in bed more than 50% of day, but not bed ridden.   20-30 Bed Ridden  CURRENT MEDICATIONS Drug Dose  Route Freguency Date (mm/dd/yyyy) To No To To To

--- Page 2 ---
 PAST MEDICAL HISTORY Diagnosis Date Treatment Status Diagnosis/Disease/Dlsorder/Injury   .OBGYN HISTORYy a  W Date of First Menses # of Pregnancies Menopausal Status  Pre-menopausal Yeasrd Date of Last Menses # of Live Births  Perl-Menopausal Post-menopausal Yenrsre!  Oral Contraceptive  Hormone Replacementd Birth Controi:  Condom  Other: ND. Therapy: SOCIALHISTORY.. Environmental Hazards: Occupation: Smoking History TYPE Packs/day Duration When Quit Current Status (yrs) (y)  yes Alcohol Consumption. TYPE Drinks/day Duratlon When Quit Current Status (yrs)  (yr)  yes NO Drug Use Duration When Quit Current Status Type Frequency (yrs) 1 (yr)  yes nO SPSFAMILYMEDICALHISTORYL Diagnosis Age of Diagnosis Relative Nohoz Las. Csilx WLABDATA   Result Date  Result Date Test Test CEA   Negative  Positive: Negative  Positive: HIV CA 15-3   Negative  Positive: Negative Hep B  Positive: CA 19-9   Negative  Positive: Hep C   Negative  Positive: PSA  Negative  Positive: AFP   Negative  Positive: Other: Other:  Negative  Positive:  Negative  Positive: B/T Cell Markers:

--- Page 3 ---
+ +**DIAGNOSTIC STUDIES Study Results Date Ultrasound X-Ray CT Endoscopy MRI Biopsy RCAAACLINICALDIAGNOSIS* + Preoperative Clinical Dlagnosis esf heaet Cnen Location of Suspected Involved'Lymph Nodes Location of Suspected Distant Metastasis A xilla No Clinical Staging Date of Diagnosis T9N1 Mo Stage: ICR Treatment Information SMPM.SURGICALTREATMENT Procedure Date of Procedure Haley's swrx? 0 Primary Tumor Organ Detailed Location Size Isea! Eppersnteogsadran 0.9x x cm Extension ot Tumor N Lymph Nodes Description Location of Lymph Nodes # of Lymph Nodes Palpable, Non-Dissected Lymph Nodes A xill 3 Dissected Lymph Nodes Distant Metastasisd Organ Detalled Location Size 190 Surgical Staging Is NA M a Stage: A .  + NEOADJUVENT THERAPY (Chemo, Radiation, Immuno, Hormonal, or Molecular) : Drug/Treatment Dose Route Frequency Date (mm/dd/yyy) To / To 1 To To TQ.

--- Page 4 ---
Pathology Form Specimen Information Collected by: Date: .me: Preserved by:. Date: AA -..ne: :y rrvts p SPECIMEN TYPE (#of samples provided) +   w+ Frozen Paraffin Block Blood/8erum/Plasma Slide Diseased  Normal Diseased  Normal Diseased Normal Diseased Normal x Time to LN2 Time to Formalin. Time to LN2 min M min 60. min RPATHOLOGICALDESCRIPTION Primary Tumor Organ Slze Extension of Tumor Distance to NAT leeay! 19 x* N0 2. cm cm Lymph Nodes Location # Examined # Metastasized Axille 42 Distant Metastasis Size Organ Detalled Location Pathological Staging N m o pTy Stage: JCA Notes:

--- Page 5 ---
CONSOLIDATED DIAGNOSTIC PATHOLOgy fORm* Microscopic Appearance: Histological pattern: CELL DISTRIBUTION Diffuse  STRUCTURAL PATTERN Streaming Mosaic X.  Storiform Necrosis Lymphocytic Infitration Fibrosis. Vascular Invasion X Palisadin Cystic Degeneration Clusterized X Bleeding Alveoiac Formation X Myxoid Chan? Indian File  PsammomaCalcification 2. Cellular features: Squamous + Adenomatous t. Sarcomatous + Lxmphomatoy! Squamoid Cell Glanduiar ce!l Round Celt Lar. Ceu.  Spindle Cell Cell Stratification Fibroblast Small Cell Keratin Secretion Osteoblast RS CeIVRS Like Desmosome Intracyt. Vacuole  Lipoblast Inflam. Cell Pear! Gland fosmation Myoblast  Plasma Cell Otherwise Specified: D7s7 Dr757o Neerm 2. Cellular Differentiation: Well Moderuely Poor X 3.Nuclear Atypia: Nuckear Appearance Aniso Nucleosis Hyperchromatism Nucleolar Prominent Multinucleated Giant Cell x  Mitotic Activity X Nuckear Grade Histological Diagnosis: Enfiltra/s?y. Auttel Csiismpsg N1, C 2 MetRtt8 zed to LN Ms.Careiromo Comments Date Director, Research Pathology PATHOLOGIST STAFF FOR RESEARCH USE ONLY).E *(INTEGRATED REPORT OF FINDINGS BY CONTRIBUTOR ANDS